News
The GOP-led House Judiciary Committee is requesting records from Pfizer’s CEO and an interview with a former company ...
U.S. lawmakers on Thursday asked Pfizer Inc for information on alleged comments by a former executive suggesting its research ...
Todays focus will be on GSK Pharma shares in light of the companys announced topline growth and profitability for the full ...
The company registered standalone net profits after tax of EGP 43.559 million in Q1 2025, compared to EGP 2.046 million in net losses during Q1 2024 ...
The move comes as GSK faces pressure to replenish its pipeline, with some of its top-selling drugs nearing the end of their ...
A former Pfizer scientist said the timing of the 2020 vaccine results “wasn’t a coincidence,” according to allegations ...
19hon MSN
Denmark's economic growth, which was driven by what economists described as an "exceptional surge" in pharmaceutical exports, ...
A kidnapped child, a husband with a double life, a treacherous murder plot unraveled when the police arrive at the perfect ...
London: GSK plc and Boston Pharmaceuticals, a clinical stage biopharmaceutical company developing highly targeted therapies ...
12h
Zacks.com on MSNGSK Inks $2B Deal With Boston Pharmaceuticals to Buy Liver Disease DrugThrough the Boston Pharma deal, GSK aims to strengthen its pipeline, as some of its key products are nearing the end of their exclusivity period.
Here are the five things you need to know in local business news to start your busy Thursday, including World Cup game prices, GSK's latest buy, how Cape Cod got its name and economic experts offer ...
Merck’s Keytruda, with more than 40 approved indications, hasn’t yet been able to crack specifically into ovarian cancer. | ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results